Search…

Hong Kong Stock Market Surges Again | CanSino Biologics (06185.HK) Rises Over 15% Again, Inhaled Tuberculosis Vaccine Approved for Clinical Trials in Indonesia, Several Vaccines Set to Enter Commercialization

21/05/2025

According to the China Fortune Financial News app, CanSino Biologics (06185.HK) has risen by over 15% again, rising by 15.6% to HK $37.9 as of press time, with a turnover of HK $652.056 million.

Latest

2 m ago

Concerns about the ongoing US fiscal deficit supported spot gold prices steadily. Pepperstone research strategist Quasar Elizundia stated that investors are reassessing the long-term outlook for US sovereign risk after Moody's downgrade of US credit rating. The demand for safe-haven assets such as gold may increase. However, if ETF funds continue to flow out, the short-term upside potential for gold prices may be limited. He pointed out that last week, a large amount of gold ETF funds flowed out, totaling 30 tons.

2 m ago

Strategist: If ETF funds continue to flow out, the short-term upside potential of gold prices may be limited.

2 m ago

Shandong Iron and Steel: Establish Sales Subsidiary Completes Industrial and Commercial Registration.

2 m ago

Black Cat Corporation: Superconducting carbon black products can be used in fast charging, solid-state and other battery products.

3 m ago

Traders are reducing their bets on a rate cut by the Bank of England, leaning towards only one more rate cut this year.

+852 - 60190728

Customer Support

Commercial Services